139 related articles for article (PubMed ID: 38438113)
1. The uptake of long-acting depot buprenorphine for treating opioid dependence in Australia, 2019-2022: longitudinal sales data analysis.
Lintzeris N; Hayes V; Dunlop AJ
Med J Aust; 2024 Apr; 220(6):339-340. PubMed ID: 38438113
[No Abstract] [Full Text] [Related]
2. Depot buprenorphine during COVID-19 in Australia: Opportunities and challenges.
Arunogiri S; Lintzeris N
J Subst Abuse Treat; 2021 May; 124():108221. PubMed ID: 33303254
[TBL] [Abstract][Full Text] [Related]
3. Rapid upscale of depot buprenorphine (CAM2038) in custodial settings during the early COVID-19 pandemic in New South Wales, Australia.
Roberts J; White B; Attalla D; Ward S; Dunlop AJ
Addiction; 2021 Feb; 116(2):426-427. PubMed ID: 32888226
[No Abstract] [Full Text] [Related]
4. Does the advent of depot therapy represent a step change in our understanding of opioid use disorder and its treatment?
Roberts E; Humphreys K
Drug Alcohol Rev; 2024 Jan; 43(1):261-264. PubMed ID: 37525510
[TBL] [Abstract][Full Text] [Related]
5. Tracing the affordances of long-acting injectable depot buprenorphine: A qualitative study of patients' experiences in Australia.
Barnett A; Savic M; Lintzeris N; Bathish R; Arunogiri S; Dunlop AJ; Haber P; Graham R; Hayes V; Lubman DI
Drug Alcohol Depend; 2021 Oct; 227():108959. PubMed ID: 34450472
[TBL] [Abstract][Full Text] [Related]
6. Buprenorphine for Persons on Waiting Lists for Treatment for Opioid Dependence.
Yan K
N Engl J Med; 2017 Mar; 376(10):1000. PubMed ID: 28276662
[No Abstract] [Full Text] [Related]
7. Buprenorphine for Persons on Waiting Lists for Treatment for Opioid Dependence.
Sigmon SC; Schwartz RP; Higgins ST
N Engl J Med; 2017 Mar; 376(10):1000-1001. PubMed ID: 28273017
[No Abstract] [Full Text] [Related]
8. Initial experience with subcutaneous depot buprenorphine in a medically supervised injecting facility.
Weeks A; Cogger S; Clark N
Drug Alcohol Rev; 2021 Nov; 40(7):1354-1355. PubMed ID: 33821545
[No Abstract] [Full Text] [Related]
9. Novel Long-Acting Buprenorphine Medications for Opioid Dependence: Current Update.
Soyka M
Pharmacopsychiatry; 2021 Jan; 54(1):18-22. PubMed ID: 33212514
[TBL] [Abstract][Full Text] [Related]
10. Rethinking Opioid Dose Tapering, Prescription Opioid Dependence, and Indications for Buprenorphine.
Chou R; Ballantyne J; Lembke A
Ann Intern Med; 2019 Sep; 171(6):427-429. PubMed ID: 31450240
[No Abstract] [Full Text] [Related]
11. Medication-Based Treatment to Address Opioid Use Disorder.
Leshner AI; Dzau VJ
JAMA; 2019 Jun; 321(21):2071-2072. PubMed ID: 31046072
[No Abstract] [Full Text] [Related]
12. Patient-Reported Outcomes of Treatment of Opioid Dependence With Weekly and Monthly Subcutaneous Depot vs Daily Sublingual Buprenorphine: A Randomized Clinical Trial.
Lintzeris N; Dunlop AJ; Haber PS; Lubman DI; Graham R; Hutchinson S; Arunogiri S; Hayes V; Hjelmström P; Svedberg A; Peterson S; Tiberg F
JAMA Netw Open; 2021 May; 4(5):e219041. PubMed ID: 33970256
[TBL] [Abstract][Full Text] [Related]
13. Use and misuse of opioid replacement therapies: a Queensland study.
Smirnov A; Kemp R
Subst Use Misuse; 2012 Jan; 47(1):78-85. PubMed ID: 22216993
[TBL] [Abstract][Full Text] [Related]
14. Treatment of opioid dependence with depot buprenorphine (CAM2038) in custodial settings.
Dunlop AJ; White B; Roberts J; Cretikos M; Attalla D; Ling R; Searles A; Mackson J; Doyle MF; McEntyre E; Attia J; Oldmeadow C; Howard MV; Murrell T; Haber PS; Lintzeris N
Addiction; 2022 Feb; 117(2):382-391. PubMed ID: 34184798
[TBL] [Abstract][Full Text] [Related]
15. Enhancing engagement between legislators and nursing to increase buprenorphine access.
Finnell DS; Schimmels J; Tierney M
Nurs Outlook; 2023; 71(4):102004. PubMed ID: 37429154
[No Abstract] [Full Text] [Related]
16. Novel forms of injectable buprenorphine and French model of opioid use disorder treatment.
Lapeyre-Mestre M
Therapie; 2020; 75(5):393-395. PubMed ID: 33039103
[No Abstract] [Full Text] [Related]
17. Time to include buprenorphine-naloxone combination in the WHO Model List of Essential Medicines.
Balhara YP
J Opioid Manag; 2013; 9(4):237. PubMed ID: 24380101
[No Abstract] [Full Text] [Related]
18. Buprenorphine Initiation: Low-Dose Methods #457.
Ho JJ; Jones KF; Merlin JS; Sager Z; Childers J
J Palliat Med; 2023 Jun; 26(6):867-869. PubMed ID: 37276524
[No Abstract] [Full Text] [Related]
19. In brief: Over-the-counter Narcan nasal spray.
Med Lett Drugs Ther; 2023 May; 65(1675):72. PubMed ID: 37155252
[No Abstract] [Full Text] [Related]
20. Low- and very low-dose buprenorphine induction: new(ish) uses for an old(ish) medication?
Weimer MB; Fiellin DA
Addiction; 2022 Jun; 117(6):1507-1509. PubMed ID: 35032081
[No Abstract] [Full Text] [Related]
[Next] [New Search]
